Case Studies

A selection of case studies from BDD covering work from formulation and clinic.

Pharmacoscintigraphy to compare fast acting aspirin to ibuprofen tablet formulations
An open label, randomized two-way crossover scintigraphic study to investigate lung deposition of radiolabelled alginate oligosaccharide delivered as a dry powder and as a nebulized solution in cystic fibrosis patients
Pharmacoscintigraphic and Pharmacokinetic Analysis of CTx-1301, a Novel Tri-modal Oral Formulation for Release of Dexmethylphenidate
Overcoming the Challenges of Radiolabeling a Gastric Retentive Formulation: Utilizing Polymer Encapsulated Indium-111 Chloride to Assess Gastroretention with Gamma Scintigraphy

Latest news

Contera Pharma and BDD Pharma announce dosing of first subject in a Phase 1 trial of CP-012, a novel formulation to treat nocturnal symptoms and morning akinesia in Parkinson´s disease

BDD Pharma Ltd Unveils Updated Logo for 2023

Latest blog posts

Revolutionising Respiratory Formulation and Device Development: The Impact and Future of Gamma Scintigraphy in Pulmonary Drug Delivery

BDD Pharma – Delivering Breakthroughs